BG104119A - A new composition - Google Patents
A new compositionInfo
- Publication number
- BG104119A BG104119A BG104119A BG10411900A BG104119A BG 104119 A BG104119 A BG 104119A BG 104119 A BG104119 A BG 104119A BG 10411900 A BG10411900 A BG 10411900A BG 104119 A BG104119 A BG 104119A
- Authority
- BG
- Bulgaria
- Prior art keywords
- new composition
- betablocker
- reversive
- serotonin
- pharmaceutical composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Addiction (AREA)
- Child & Adolescent Psychology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Hospice & Palliative Care (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9714675.7A GB9714675D0 (en) | 1997-07-11 | 1997-07-11 | Novel composition |
PCT/EP1998/004971 WO1999002142A2 (en) | 1997-07-11 | 1998-07-07 | Novel composition comprising an ssri and a beta-blocker |
Publications (1)
Publication Number | Publication Date |
---|---|
BG104119A true BG104119A (en) | 2000-12-29 |
Family
ID=10815744
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BG104119A BG104119A (en) | 1997-07-11 | 2000-02-01 | A new composition |
Country Status (26)
Country | Link |
---|---|
EP (1) | EP0996466A2 (xx) |
JP (1) | JP2002508003A (xx) |
KR (1) | KR20010021644A (xx) |
CN (1) | CN1262627A (xx) |
AP (1) | AP2000001728A0 (xx) |
AR (1) | AR016128A1 (xx) |
AU (1) | AU9340198A (xx) |
BG (1) | BG104119A (xx) |
BR (1) | BR9810996A (xx) |
CA (1) | CA2295822A1 (xx) |
CO (1) | CO4950552A1 (xx) |
DZ (1) | DZ2556A1 (xx) |
EA (1) | EA200000112A1 (xx) |
GB (1) | GB9714675D0 (xx) |
HU (1) | HUP0003074A3 (xx) |
ID (1) | ID24191A (xx) |
IL (1) | IL133869A0 (xx) |
MA (1) | MA24604A1 (xx) |
NO (1) | NO20000107L (xx) |
OA (1) | OA11276A (xx) |
PE (1) | PE99699A1 (xx) |
PL (1) | PL338017A1 (xx) |
SK (1) | SK72000A3 (xx) |
TR (1) | TR200000074T2 (xx) |
WO (1) | WO1999002142A2 (xx) |
ZA (1) | ZA986138B (xx) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1121111B1 (en) | 1998-10-15 | 2010-02-10 | Imperial Innovations Limited | Compounds for the treatment of weight loss |
IL142896A0 (en) | 1998-11-02 | 2002-04-21 | Elan Corp Plc | Multiparticulate modified release composition |
MXPA02004293A (es) | 1999-10-29 | 2002-10-31 | Euro Celtique Sa | Formulaciones de hidrocodona de liberacion controlada.. |
US10179130B2 (en) | 1999-10-29 | 2019-01-15 | Purdue Pharma L.P. | Controlled release hydrocodone formulations |
GB0004003D0 (en) * | 2000-02-22 | 2000-04-12 | Knoll Ag | Therapeutic agents |
CN100518827C (zh) | 2000-10-30 | 2009-07-29 | 欧罗赛铁克股份有限公司 | 控释氢可酮制剂 |
AU2005283829A1 (en) * | 2004-09-17 | 2006-03-23 | Neurocure Ltd | Pindolol for the treating premenstrual syndrome and premenstrual dysphoric disorder |
CN100469356C (zh) * | 2006-09-08 | 2009-03-18 | 山东益康药业有限公司 | 复方阿替洛尔缓释片及其制备方法 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2732335C2 (de) * | 1976-07-27 | 1983-01-20 | Sandoz-Patent-GmbH, 7850 Lörrach | Tablette zur enteralen Verabreichung von Indolyloxyalkanolamin-Derivaten |
CA2134038C (en) * | 1994-06-16 | 1997-06-03 | David Taiwai Wong | Potentiation of drug response |
EP0714663A3 (en) * | 1994-11-28 | 1997-01-15 | Lilly Co Eli | Potentiation of drug responses by serotonin 1A receptor antagonists |
DK0759299T3 (da) * | 1995-08-16 | 2000-08-07 | Lilly Co Eli | Potensering af serotoninrespons |
EP0792649A1 (en) * | 1996-02-29 | 1997-09-03 | Eli Lilly And Company | Treatment of sleep disorders |
-
1997
- 1997-07-11 GB GBGB9714675.7A patent/GB9714675D0/en active Pending
-
1998
- 1998-07-07 CN CN98806975A patent/CN1262627A/zh active Pending
- 1998-07-07 KR KR1020007000202A patent/KR20010021644A/ko not_active Application Discontinuation
- 1998-07-07 WO PCT/EP1998/004971 patent/WO1999002142A2/en not_active Application Discontinuation
- 1998-07-07 BR BR9810996-0A patent/BR9810996A/pt not_active Application Discontinuation
- 1998-07-07 SK SK7-2000A patent/SK72000A3/sk unknown
- 1998-07-07 AP APAP/P/1999/001728A patent/AP2000001728A0/en unknown
- 1998-07-07 IL IL13386998A patent/IL133869A0/xx unknown
- 1998-07-07 EA EA200000112A patent/EA200000112A1/ru unknown
- 1998-07-07 ID IDW20000035A patent/ID24191A/id unknown
- 1998-07-07 JP JP50818599A patent/JP2002508003A/ja active Pending
- 1998-07-07 AU AU93401/98A patent/AU9340198A/en not_active Abandoned
- 1998-07-07 CA CA002295822A patent/CA2295822A1/en not_active Abandoned
- 1998-07-07 PL PL98338017A patent/PL338017A1/xx unknown
- 1998-07-07 EP EP98946294A patent/EP0996466A2/en not_active Withdrawn
- 1998-07-07 TR TR2000/00074T patent/TR200000074T2/xx unknown
- 1998-07-07 HU HU0003074A patent/HUP0003074A3/hu unknown
- 1998-07-08 DZ DZ980166A patent/DZ2556A1/xx active
- 1998-07-10 MA MA25165A patent/MA24604A1/fr unknown
- 1998-07-10 CO CO98039260A patent/CO4950552A1/es unknown
- 1998-07-10 PE PE1998000612A patent/PE99699A1/es not_active Application Discontinuation
- 1998-07-10 ZA ZA9806138A patent/ZA986138B/xx unknown
- 1998-07-10 AR ARP980103371A patent/AR016128A1/es unknown
-
2000
- 2000-01-10 NO NO20000107A patent/NO20000107L/no not_active Application Discontinuation
- 2000-01-11 OA OA1200000006A patent/OA11276A/en unknown
- 2000-02-01 BG BG104119A patent/BG104119A/xx unknown
Also Published As
Publication number | Publication date |
---|---|
NO20000107D0 (no) | 2000-01-10 |
AU9340198A (en) | 1999-02-08 |
ZA986138B (en) | 2000-01-10 |
ID24191A (id) | 2000-07-13 |
AR016128A1 (es) | 2001-06-20 |
EP0996466A2 (en) | 2000-05-03 |
WO1999002142A3 (en) | 1999-04-15 |
PL338017A1 (en) | 2000-09-25 |
HUP0003074A2 (hu) | 2001-01-29 |
KR20010021644A (ko) | 2001-03-15 |
WO1999002142A2 (en) | 1999-01-21 |
AP2000001728A0 (en) | 2000-03-31 |
NO20000107L (no) | 2000-01-10 |
CN1262627A (zh) | 2000-08-09 |
OA11276A (en) | 2003-07-31 |
BR9810996A (pt) | 2000-08-08 |
TR200000074T2 (tr) | 2000-05-22 |
MA24604A1 (fr) | 1999-04-01 |
IL133869A0 (en) | 2001-04-30 |
PE99699A1 (es) | 1999-12-21 |
CO4950552A1 (es) | 2000-09-01 |
DZ2556A1 (fr) | 2003-02-15 |
CA2295822A1 (en) | 1999-01-21 |
JP2002508003A (ja) | 2002-03-12 |
HUP0003074A3 (en) | 2001-12-28 |
EA200000112A1 (ru) | 2000-10-30 |
GB9714675D0 (en) | 1997-09-17 |
SK72000A3 (en) | 2000-12-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CZ20011427A3 (cs) | Farmaceutická kompozice s řízeným uvolňovaním obsahující inhibitor CGMP DPE-5 | |
ZA981132B (en) | Methods, compositions and articles for reducing or preventing the effects of inflammation. | |
BG101139A (en) | Heteroatoms-containing cyclopentanopyridyloxazolidinons | |
GB2365772A (en) | Factor | |
MXPA98004611A (es) | Composicion inhibidora de flama y uso de la misma. | |
ZA987537B (en) | Stanol ester composition and production thereof. | |
LU91758I9 (xx) | ||
BG101132A (en) | Pyridoanilated thienyl and furanyl oxazolidinons | |
YU15299A (sh) | Farmaceutski sastavi | |
IL122447A0 (en) | Pharmaceutical composition with anaestheric effect | |
IL147803A0 (en) | 28-epirapalogs | |
HU9400952D0 (en) | Heteroaryl-amines as acetyl-cholinesterase inhibitors | |
ZA9710593B (en) | Antisebum and antioxidant compositions containing gugulipid and fractions thereof. | |
AP2000002010A0 (en) | Novel pharmaceutical compositions for treating and saving and the methods for the preparation thereof | |
GB9717598D0 (en) | Novel composition and use | |
BG104119A (en) | A new composition | |
BG101401A (en) | Cisaspide extended release oral compositions | |
PL353214A1 (en) | Substituted 3-phenyl-5-alkoxi-1,3,4-oxdiazol-2-ones and their use as lipase inhibitors | |
BG100248A (en) | Squalene synthetase inhibitors | |
MD970269A (en) | Clavulanates | |
ZA949874B (en) | B3-adrenergic agents, benzodioxole dicarboxylates and their use in pharmaceutical compositions. | |
UA48245C2 (uk) | ЗАМІЩЕНІ 1,2,3,4-ТЕТРАГІДРО-2-ДИБЕНЗОФУРАНАМІНИ ТА 2-АМІНОЦИКЛОГЕПТА[B]БЕНЗОФУРАНИ, ФАРМАЦЕВТИЧНА ЛІКАРСЬКА ФОРМА ТА СПОСІБ ПІДВИЩЕННЯ АКТИВАЦІЇ 5-НТ<sub>1F</sub> РЕЦЕПТОРА У ССАВЦЯ | |
BG101849A (en) | Bicyclic tachyquinine antagonists, their preparation and use in pharmaceutical compositions | |
GB9606579D0 (en) | Pharmaceutical composition and methods for the manufacture thereof | |
NZ326769A (en) | High-content famciclovir tablets |